Skin Disease
L’Oréal, ILDS partner for global dermatologic accessibility study
A global study of dermatology accessibility has been launched in 194 countries through a collaboration between the L’Oréal Groupe’s Skin Alliance Forum and the International League of Dermatological Societies.
Clinical Presentation of Psoriatic Arthritis
The CASPAR classification criteria for psoriatic arthritis (PsA) identify any one of these as a necessary indication of inflammatory articular disease before the other components of the criteria may be applied. Concurrent psoriasis is not always present in patients with PsA. There may be a history of prior skin disease or perhaps even no skin disease in patients whose initial presentation is joint disease.
Beneath the Surface: How to embrace AI responsibly with Roxana Daneshjou, MD, PhD
Beneath the Surface is a video series in which Joel M. Gelfand, MD, MSCE, Healio Dermatology Chief Medical Editor, discusses hot topics in the field with leading experts.
Prurigo Control Test shows potential for disease evaluation in clinical practice, trials
Researchers have developed and validated a new tool for evaluating disease control among patients with chronic prurigo, according to a study.
World Mental Health Day: Hidden burdens of skin disease include stigmatization
Each year, WHO marks World Mental Health Day on Oct. 10 in an effort to raise awareness of mental health issues around the world and mobilize efforts to support mental health.
Juvenile dermatomyositis skin disease more active than muscle involvement
Disconnect amid dual diagnosis: Managing the mental toll of psoriasis, PsA
The gap between patient-reported outcomes and clinician-assessed endpoints in rheumatology is well documented. Patients generally care about pain, fatigue and the emotional toll immune-mediated diseases can take, while physicians are more likely to pay attention to interleukin activity or C-reactive protein levels.
Sociodemographic background may affect ‘not relevant’ responses on DLQI
Gender, income and marital status may predict the likelihood of reporting “not relevant” to certain questions on the Dermatology Life Quality Index among patients with psoriasis, suggesting a possible underestimation of disease burden, according to recent findings.